logo

Perrigo Co. (PRGO)



Trade PRGO now with
  Date
  Headline
8/9/2018 12:13:48 AM Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
8/9/2018 12:08:13 AM Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business
8/9/2018 12:04:45 AM Perrigo Company Q2 Reported EPS $0.26 Vs Loss $0.49 Last Year
8/1/2018 8:49:05 AM Perrigo Declares Quarterly Dividend Of $0.19/Shr; Record August 31/Payable September 18
8/1/2018 8:47:28 AM Perrigo Co. (PRGO) Declares Quarterly Dividend of $ 0.19, Record Date 8/31/2018
5/24/2018 8:36:02 AM Perrigo Confirms Patent Challenge For Generic Version Of Sernivo Spray, 0.05%
5/14/2018 9:25:57 AM Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate Lotion, 0.05%
5/9/2018 2:41:01 PM RBC Capital Markets Is Raising Perrigo Co. (PRGO) 2020 Estimate To 5.84 From 5.81
5/9/2018 2:40:41 PM RBC Capital Markets Is Increasing Perrigo Co. (PRGO) 2019 Estimate To 5.62 From 5.59
5/9/2018 2:40:23 PM RBC Capital Markets Is Cutting Perrigo Co. (PRGO) 2018 Estimate To 5.23 From 5.24
5/9/2018 2:39:48 PM RBC Capital Markets Is Cutting Perrigo Co. (PRGO) 2020 Rev. Estimate To 5.309 Billion From 5.316 Billion
5/9/2018 2:39:30 PM RBC Capital Markets Is Lowering Perrigo Co. (PRGO) 2019 Rev. Estimate To 5.185 Billion From 5.204 Billion
5/9/2018 2:39:14 PM RBC Capital Markets Is Cutting Perrigo Co. (PRGO) 2018 Rev. Estimate To 5.039 Billion From 5.049 Billion